Cargando…
miR-149-5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway
Chemotherapeutic resistance remains a critical clinical issue is responsible for treatment failure in patients with ovarian cancer. Evidence of the involvement of miRNAs in chemoresistance in ovarian cancer has been recently emerging. However, the underlying molecular links between chemoresistance a...
Autores principales: | Xu, Manman, Xiao, Juan, Chen, Ming, Yuan, Linjing, Li, Jundong, Shen, Hongwei, Yao, Shuzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807033/ https://www.ncbi.nlm.nih.gov/pubmed/29393390 http://dx.doi.org/10.3892/ijo.2018.4252 |
Ejemplares similares
-
Downregulation of miR-874-3p promotes chemotherapeutic resistance in colorectal cancer via inactivation of the Hippo signaling pathway
por: Que, Kaiqian, et al.
Publicado: (2017) -
miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo Signaling in Thyroid Cancer
por: Liu, Xiaoli, et al.
Publicado: (2019) -
miR-149 in Human Cancer: A Systemic Review
por: He, Yunjie, et al.
Publicado: (2018) -
miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1
por: Xu, Juan, et al.
Publicado: (2017) -
TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway
por: Wang, Xu, et al.
Publicado: (2018)